Skip to main content

Your search for “Neutralization” returned 164 results

Imitation May Be a Sincere Form of Treatment

August 5, 2020

The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.

UC San Diego Joins Second Major National Clinical Trial for Novel Coronavirus

September 2, 2020

UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.

UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine

October 1, 2020

UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.

UC San Diego Selected to Lead International HIV/AIDS Clinical Trials Unit

November 30, 2020

University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.

New ‘Split-drive’ System Puts Scientists in the (Gene) Driver Seat

March 5, 2021

New research published in two papers by UC San Diego scientists describes novel achievements designed to make the implementation of gene drives safer and more controllable. The new split drive and home-and-rescue systems address concerns about the release of gene drives in wild populations.

How Well do COVID-19 Vaccines Work Over the Longer Term?

April 1, 2021

UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.

AI Predicts How Patients with Viral Infections, Including COVID-19, Will Fare

June 11, 2021

UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies — for current and future pandemics.

For Transplant Patients, COVID-19 Vaccination Presents a Different Uncertainty

July 1, 2021

Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney.

UC San Diego Named Top 10 Public University by U.S. News & World Report

September 13, 2021

U.S. News & World Report has once again named the University of California San Diego among the best colleges in the country. Released today, the U.S. News & World Report 2022 Best Colleges rankings listed UC San Diego as the nation’s eighth best public university.

UC San Diego Biology Lab Receives $1.4M Grant to Fight Malaria Spread

March 30, 2022

New funding from the Gates Foundation will support cutting-edge genetics strategies designed implement and safely restrain gene drives that help stop the spread of malaria, which annually infects more than 200 million people.

Category navigation with Social links